SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-20-021700
Filing Date
2020-02-14
Accepted
2020-02-14 16:06:46
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVEF MANAGEMENT V, LLCVENROCK ENTREPRENEURS FUND V, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.VENROCK MANAGEMENT V, LLCVENROCK PARTNERS MANAGEMENT V, LLCVENROCK PARTNERS V, L.P.VHCP CO

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207551d2_sc13ga.htm SC 13G/A 301889
  Complete submission text file 0001104659-20-021700.txt   303901
Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650-475-3734
VENROCK ASSOCIATES V LP (Filed by) CIK: 0001391289 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Subject) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90572 | Film No.: 20619531
SIC: 2834 Pharmaceutical Preparations